Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)
How does Ketamine Therapy work Neuroplasticity Ketamine dramatically reorganizes activity in the brain, as if a switch is being flipped on its active circuits
Modulation of Inflammatory Pathways Persistent tendon pain is not always driven by inflammation alone, but inflammatory signaling can still play an important role, especially in the early stages of injury
With personalized insights and tailored recommendations, AI helps patients stay engaged, optimize their treatment, and achieve better outcomes
Case Study Reflection Risk Factors for DVT Marias risk factors for developing deep vein thrombosis (DVT) include her age (over 65), obesity (BMI 32), history of hypertension and diabetes, and atrial fibrillation
[1] Healthcare providers may recommend diagnostic evaluation if bloating is atypical or concerning
